Mcdonald Partners LLC Boosts Position in Colgate-Palmolive (NYSE:CL)

Mcdonald Partners LLC raised its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,996 shares of the company’s stock after acquiring an additional 172 shares during the period. Mcdonald Partners LLC’s holdings in Colgate-Palmolive were worth $909,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in CL. FMR LLC lifted its position in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the period. Barclays PLC raised its stake in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the last quarter. State Street Corp lifted its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after buying an additional 1,784,411 shares during the period. Nordea Investment Management AB boosted its stake in shares of Colgate-Palmolive by 32.5% in the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock worth $462,121,000 after buying an additional 1,247,731 shares during the last quarter. Finally, AustralianSuper Pty Ltd grew its holdings in Colgate-Palmolive by 941.9% during the fourth quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company’s stock worth $103,515,000 after acquiring an additional 1,029,364 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 1.9 %

CL stock opened at $86.10 on Tuesday. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The firm has a 50-day moving average of $89.39 and a two-hundred day moving average of $96.22. Colgate-Palmolive has a 12 month low of $83.20 and a 12 month high of $109.30. The company has a market cap of $70.34 billion, a price-to-earnings ratio of 24.46, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm earned $0.87 earnings per share. As a group, analysts forecast that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.32%. Colgate-Palmolive’s payout ratio is 56.82%.

Wall Street Analyst Weigh In

CL has been the topic of several recent research reports. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. JPMorgan Chase & Co. decreased their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Stifel Nicolaus dropped their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.